Moderator: John G. DeVine, MD
232. Importance of sagittal alignment in cervical spondylotic myelopathy: an observational study from the Canadian Spine Outcomes and Research Network
Nathan Evaniew, MD, PhD, FRCSC1; Raphaële Charest-Morin, MD2; Bradley Jacobs, MD, FRCSC3; Michael G. Johnson, MD, FRCSC4; Christopher S. Bailey, MD, FRCSC5; Sean D. Christie, MD6; Jerome Paquet, MD, FRCSC2; Andrew Nataraj, MSc, MD, FRCSC7; David W. Cadotte, MD, PhD8; Jefferson Wilson, MD, PhD, FRCSC9; Neil A. Manson, MD, FRCSC10; Hamilton Hall, MD, FRCSC11; Kenneth C. Thomas, MD, FRCS12; Raja Y. Rampersaud, MD, FRCSC13; Greg McIntosh, BS14; Charles G. Fisher, MD, FRCSC, MHS15; Nicolas Dea, MD, MSc, FRCSC16
1Vancouver, BC, Canada; 2Quebec, QC, Canada; 3University of Calgary, Foothills Hospital, Calgary, AB, Canada; 4Health Sciences Centre Winnipeg Spine Program, Winnipeg, MB, Canada; 5U of Western Ontario/London Health Sciences Centre, London, ON, Canada; 6QE II Health Sciences Centre, Halifax, NS, Canada; 7Division of Neurosurgery, Edmonton, AB, Canada; 8University of Toronto, Toronto, ON, Canada; 9St. Michael's Hospital, University of Toronto, Toronto, Canada; 10Canada East Spine Cantre, Saint John, NB, Canada; 11Markdale, ON, Canada; 12Foothills Medical Centre, Calgary, AB, Canada; 13Toronto Western Hospital, Toronto, ON, Canada; 14Canadian Spine Society, Oakville, ON, Canada; 15Vancouver General Hospital, Vancouver, BC, Canada; 16Blusson Spinal Cord Center, Vancouver, BC, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
233. Does postoperative physical therapy improve patient-reported outcomes at one-year following cervical spine surgery?
Kristin R. Archer, PhD, DPT1; Jacquelyn S. Pennings, PhD1; Inamullah Khan, MD1; Ahilan Sivaganesan, MD1; JP Wanner, MD2; Daniel R. Verhotz, MD1; Rogelio A. Coronado, PT, PhD1; Clinton J. Devin, MD1; Emily R. Oleisky1
1Vanderbilt University Medical Center, Nashville, TN, US; 2Nashville, TN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
234. The residual arm numbness after laminoplasty for the patients with cervical spondylotic myelopathy
Masayoshi Iwamae, MD1; Koji Tamai, MD2; Akinobu Suzuki, MD, PhD2; Hidetomi Terai, MD, PhD3; Masatoshi Hoshino, MD3; Hiromitsu Toyoda, MD, PhD2; Shinji Takahashi, MD2; Hiroaki Nakamura, MD, PhD4
1Shimada Hospital, Osaka, Japan; 2Osaka City University, Osaka, Japan; 3Dept. of Orthopaedic Surgery, Osaka City University, Graduate School of Medicine, Osaka, Japan; 4Osaka City University, Graduate School of Medicine, Osaka, Japan
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
235. Refining risk-adjustment for bundled payment models in cervical fusions: an analysis of medicare beneficiaries
Azeem T. Malik, MBBS1; Frank M. Phillips, MD2; Sheldon Retchin, MD3; Wendy Xu, PhD3; Elizabeth Yu, MD1; Jeffery Kim, MD1; Safdar N. Khan, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Midwest Orthopaedics At Rush, Chicago, IL, US; 3Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
236. Laminoplasty versus laminectomy and fusion for multi-level cervical spondylotic myelopathy with increased signal intensity on magnetic resonance imaging
Jia Nan Zhang, MD
Xi’an, Shaan'Xi, China
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion
237. Robotic-guided placement of cervical pedicle screws: feasibility and accuracy
Isador H. Lieberman, MD, FRCSC, MBA1; Xiaobang Hu, PhD1; Stanley Kisinde, MbChB2; Shea L. Hesselbacher3
1Scoliosis and Spine Tumor Center, Texas Back Institute, Texas Health Presbyterian Hospital Plano, Plano, TX, US; 2Scoliosis & Spine Tumor Center, Texas Back Institute, Plano, TX, US; 3Texas Back Institute, Plano, TX, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
238. Same day surgical intervention dramatically minimizes complication occurrence and optimizes perioperative outcomes for central cord syndrome
Cole Bortz, BA1; Avery Brown, BS2; Haddy Alas, BS2; Muhammad B. Janjua, MD3; Katherine E. Pierce, BS1; Paul Park, MD4; Charles Wang, MD5; Elizabeth L. Lord, MD2; Dimitrios C. Nikas, MD6; Aaron Hockley, MD, FRCSC7; Alexandra Soroceanu, MD, MPH8; Rafael De la Garza Ramos, MD9; Daniel M. Sciubba, MD10; Anthony K. Frempong-Boadu, MD11; Dennis Vasquez-Montes, MS, BA2; Bassel G. Diebo, MD12; Michael C. Gerling, MD13; Peter G. Passias, MD14
1New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3Dallas, TX, US; 4University Of Michigan - Dept of Neurosurgery, Ann Arbor, MI, US; 5NYU Langone Health, New York, NY, US; 6University of Illinois at Chicago, Chicago, IL, US; 7University of Alberta, Edmonton, AB, Canada; 8University of Calgary, Calgary, Canada; 9Montefiore Medical Center, Department of Neurosurgery, Spine Research Group, Bronx, NY, US; 10John Hopkins University/School of Medicine, Baltimore, MD, US; 11NYU Medical CenterDept. of Neurosurgery, New York, NY, US; 12Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 13NYU Langone, Brooklyn, Brooklyn, NY, US; 14NY Spine Institute, NYU Langone Health, New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
239. Prospective analysis of functional outcome of single stage surgical treatment for symptomatic tandem spinal stenosis
Manoj Singrakhia, MD
Shanta Spine Hospital, Nagpur, MS, India
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
240. Spinopelvic alignment and successful outcomes following cervical deformity correction
Themistocles S. Protopsaltis, MD1; Ethan W. Ayres, MPH1; Robert K. Eastlack, MD2; Justin S. Smith, MD, PhD3; D. Kojo Hamilton, MD4; Alan H. Daniels, MD5; Eric O. Klineberg, MD6; Brian J. Neuman, MD7; Robert A. Hart, MD8; Shay Bess, MD9; Christopher I. Shaffrey, MD10; Frank J. Schwab, MD11; Virginie Lafage, PhD11; Christopher P. Ames, MD12; International Spine Study Group13
1Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; 2Scripps Clinic, San Diego, CA, US; 3UVA Health System, Charlottesville, VA, US; 4University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 5Warren Alpert Medical School of BU/RI Hospital, Providence, RI, US; 6UC, Davis School of Medicine, Sacramento, CA, US; 7Baltimore, MD, US; 8Swedish Neuroscience Institute, Seattle, WA, US; 9Denver, CO, US; 10University of Virginia, Charlottesville, VA, US; 11Hospital for Special Surgery, New York, NY, US; 12University of California, San Francisco, San Francisco, CA, US; 13Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
241. Towards a cervical deformity-specific outcome instrument: use of the patient-generated index to capture the disability of cervical deformity
Nicholas Stekas, BS1; Themistocles S. Protopsaltis, MD2; Ethan W. Ayres, MPH2; Gregory M. Mundis Jr., MD3; Justin S. Smith, MD, PhD4; D. Kojo Hamilton, MD5; Eric O. Klineberg, MD6; Daniel M. Sciubba, MD7; Robert A. Hart, MD8; Shay Bess, MD9; Christopher I. Shaffrey, MD10; Frank J. Schwab, MD11; Virginie Lafage, PhD11; Christopher P. Ames, MD12; International Spine Study Group13
1New York, NY, US; 2Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital, NYU Langone Health, New York, NY, US; New York, NY, US; 3Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 4UVA Health System, Charlottesville, VA, US; 5University of Pittsburgh School of Medicine, Pittsburgh, PA, US; 6UC, Davis School of Medicine, Sacramento, CA, US; 7John Hopkins University/School of Medicine, Baltimore, MD, US; 8Swedish Neuroscience Institute, Seattle, WA, US; 9Denver, CO, US; 10University of Virginia, Charlottesville, VA, US; 11Hospital for Special Surgery, New York, NY, US; 12University of California, San Francisco, San Francisco, CA, US; 13Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion